Correlation Between Samsung Biologics and Samlip General

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Samsung Biologics and Samlip General at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Samsung Biologics and Samlip General into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Samsung Biologics Co and Samlip General Foods, you can compare the effects of market volatilities on Samsung Biologics and Samlip General and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Samsung Biologics with a short position of Samlip General. Check out your portfolio center. Please also check ongoing floating volatility patterns of Samsung Biologics and Samlip General.

Diversification Opportunities for Samsung Biologics and Samlip General

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Samsung and Samlip is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Samsung Biologics Co and Samlip General Foods in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Samlip General Foods and Samsung Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Samsung Biologics Co are associated (or correlated) with Samlip General. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Samlip General Foods has no effect on the direction of Samsung Biologics i.e., Samsung Biologics and Samlip General go up and down completely randomly.

Pair Corralation between Samsung Biologics and Samlip General

Assuming the 90 days trading horizon Samsung Biologics Co is expected to under-perform the Samlip General. But the stock apears to be less risky and, when comparing its historical volatility, Samsung Biologics Co is 1.04 times less risky than Samlip General. The stock trades about -0.08 of its potential returns per unit of risk. The Samlip General Foods is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest  4,825,000  in Samlip General Foods on September 12, 2024 and sell it today you would lose (195,000) from holding Samlip General Foods or give up 4.04% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Samsung Biologics Co  vs.  Samlip General Foods

 Performance 
       Timeline  
Samsung Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Samsung Biologics Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Samsung Biologics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Samlip General Foods 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Samlip General Foods has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Samsung Biologics and Samlip General Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Samsung Biologics and Samlip General

The main advantage of trading using opposite Samsung Biologics and Samlip General positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Samsung Biologics position performs unexpectedly, Samlip General can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Samlip General will offset losses from the drop in Samlip General's long position.
The idea behind Samsung Biologics Co and Samlip General Foods pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
CEOs Directory
Screen CEOs from public companies around the world
Stocks Directory
Find actively traded stocks across global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.